TELMIKIND TRIO 6.25 TAB
Rs 120.78 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
TELMIKIND TRIO 6.25 TAB
Telmikind Trio 6.25mg Tablet is a combination medication designed to provide comprehensive management of high blood pressure (hypertension). It includes Telmisartan, an angiotensin II receptor blocker that relaxes blood vessels; Amlodipine, a calcium channel blocker that reduces the heart's workload; and Chlorthalidone, a diuretic that helps eliminate excess fluid from the body. This triple-action approach is particularly useful for patients who require more aggressive treatment to achieve optimal blood pressure control. The medication should be used under medical supervision, especially for individuals with liver or kidney issues. It is not recommended for use during pregnancy due to potential risks to the fetus. Common side effects may include dizziness, dehydration, and swelling in the feet, which should be monitored closely by a healthcare provider. Regular follow-up is essential to ensure the medication's effectiveness and to make any necessary dosage adjustments.
Product Highlights and Usage:
Triple-Action Therapy: Contains Telmisartan, Amlodipine, and Chlorthalidone for comprehensive hypertension management. Mechanism of Action: Telmisartan relaxes blood vessels, Amlodipine reduces heart workload, and Chlorthalidone acts as a diuretic. Indications: Effective for patients needing intensive treatment for uncontrolled hypertension. Precautionary Use: Not recommended for pregnant women or those with severe liver or kidney conditions. Side Effects: May include dizziness, dehydration, electrolyte imbalances, and swelling in the feet.
How it works:
TELMIKIND TRIO 6.25MG TABLET effectively lowers blood pressure through a combination of actions. Chlorthalidone increases the excretion of sodium and water, which helps relax blood vessels. Cilnidipine relaxes blood vessels by blocking calcium entry, which is essential for smooth muscle contraction. Telmisartan works by inhibiting the effects of Angiotensin II, a substance that causes blood vessel constriction.
Directions for use:
Take TELMIKIND TRIO 6.25MG TABLET exactly as prescribed by your physician. Swallow the tablet whole; do not crush or chew it. Your doctor will determine the appropriate dosage and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY TELMIKIND TRIO 6.25MG TABLET is not recommended during early pregnancy and should be avoided after the third month of pregnancy, as it may pose serious risks to the baby. Consult your doctor for advice if you are pregnant, planning to become pregnant, or if you become pregnant while on this medication. BREASTFEEDING TELMIKIND TRIO 6.25MG TABLET is not advised for breastfeeding women because it may pass into breast milk. Your doctor may suggest alternative treatments, especially if you are breastfeeding a newborn or a premature baby. Consult your doctor before using this medication. DRIVING AND USING MACHINES Avoid driving or operating machinery if you feel dizzy or fatigued after taking TELMIKIND TRIO 6.25MG TABLET. Consult your doctor before taking this medication if you have concerns about its effects on your ability to drive or use machinery. ALCOHOL Avoid alcohol consumption while taking TELMIKIND TRIO 6.25MG TABLET, as it may exacerbate side effects. KIDNEY TELMIKIND TRIO 6.25MG TABLET is not recommended for individuals with kidney failure. Use with caution in patients with kidney disease, renal artery stenosis (narrowing of the blood vessels to one or both kidneys), or those who have undergone a kidney transplant. Consult your doctor before use. LIVER TELMIKIND TRIO 6.25MG TABLET is not recommended for patients with liver failure or severe liver conditions such as cholestasis or biliary obstruction. It should be used with caution in cases of progressive liver disease. Consult your doctor before use. ALLERGY Do not use TELMIKIND TRIO 6.25MG TABLET if you are allergic to Chlorthalidone, Cilnidipine, Telmisartan, or any other ingredients in this medication. HEART DISEASE TELMIKIND TRIO 6.25MG TABLET is not recommended for patients with cardiogenic shock (where the heart cannot pump enough blood to other organs), myocardial infarction (heart attack), acute unstable angina, or aortic stenosis (narrowing of the aorta). Use with caution in patients with low blood pressure due to dehydration, low salt intake, diarrhea, or vomiting. Consult your doctor for advice.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$